Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.
Kristi A
KA
Sacco
Cerissa
C
Creeden
Erin L
EL
Reutenauer
Tony P
TP
George
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001288:Attention; D003072:Cognition Disorders / Q000175:diagnosis* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008570:Memory, Short-Term; D008875:Middle Aged; D009483:Neuropsychological Tests; D011597:Psychomotor Performance; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012907:Smoking / Q000523:psychology*; D016540:Smoking Cessation / Q000523:psychology
D000806:Angiotensin-Converting Enzyme Inhibitors; D005702:Galantamine